What Analysts Think of AMD Stock Ahead of Earnings
Advanced Micro Devices is set to report its fourth-quarter results after the market closes Tuesday, with analysts projecting revenue and earnings growth.
Advanced Micro Devices is set to report its fourth-quarter results after the market closes Tuesday, with analysts projecting revenue and earnings growth.
Nvidia shares fell Monday after the Trump administration said it would impose tariffs, adding to steep losses for the stock that were fueled by concerns related to the success of Chinese startup DeepSeek's low-cost AI model. Watch these important chart levels.
Amazon is slated to report its fourth-quarter results after the market closes Thursday, with analysts overwhelmingly bullish on the tech titan's stock.
It will be tough for Intel to fix itself, Microsoft co-founder Bill Gates says.
Markets may be underestimating the risks of Trump’s China tariffs, experts warn.
The selloff subsided when Trump announced the tax hike on Mexican imports would be postponed for one month.
New tariffs pose a significant challenge for U.S. refiners, who are already grappling with declining profit margins. The post Energy markets panic over tariffs, but then relax appeared first on FreightWaves.
(Bloomberg) -- Palantir Technologies Inc.’s hefty premium will be in focus when the data analysis software giant reports earnings after the market close on Monday — with the stock trading at levels some see as difficult to maintain. Most Read from BloombergNew York’s First ‘Passive House’ School Is a Model of Downtown DensityWhen French Communists Went on a Brutalist Building BoomTrump Paves the Way to Deputize Local Police on ImmigrationHow the 2025 Catholic Jubilee Is Reshaping RomeHistoric Lo
Stocks fell on Monday as markets reacted to President Trump’s decision to impose tariffs on America’s three largest trading partners, sparking concerns a trade war could hit consumer and corporate finances.
Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.